EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts

Qian Yang, Yan Niu, Jian-Xun Wen, Dan-Ni Yang, Yu-Ling Han, Xu-Hui Wen, Li Yan, Jin-Hong Huang, Hong Chen, Wen-Qi Zheng, Ting-Wang Jiang, Zhi-De Hu iD

Therapeutic Advances in Respiratory Disease · 2023

DOI: 10.1177/17534666231216566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2023. Verfasst von Qian Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Pleural Effusion, Pleural Effusion, Malignant. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Natural and Science Foundation of Inner Mongolia Autonomous Region for Distinguished Young Scholars, The Science and Development Program of Gusu School, Nanjing Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung cancer is the most common cause of malignant pleural effusion (MPE). Serum human epididymis secretory protein 4 (HE4) is a useful diagnostic marker for lung cancer.

Objective

This study aimed to evaluate the diagnostic accuracy of pleural fluid HE4 for MPE.

Design

A prospective, double-blind diagnostic test accuracy study.

Methods

Patients with undiagnosed pleural effusion were enrolled in two cohorts (Hohhot and Changshu). Electrochemiluminescence immunoassay was used to detect pleural fluid HE4. The diagnostic accuracy of HE4 was evaluated by a receiver operating characteristic (ROC) curve, and the net benefit of HE4 was assessed by a decision curve analysis (DCA).

Results

A total of 66 MPEs and 86 benign pleural effusions (BPEs) were enrolled in the Hohhot cohort. In the Changshu cohort, 26 MPEs and 32 BPEs were enrolled. In both cohorts, MPEs had significantly higher pleural fluid HE4 than BPEs. The area under the ROC curve (AUC) of HE4 was 0.73 (95% CI: 0.64–0.81) in the Hohhot cohort and 0.79 (95% CI: 0.67–0.91) in the Changshu cohort. At a threshold of 1300 pmol/L, HE4 had sensitivities of 0.44 (95% CI: 0.33–0.56) in the Hohhot cohort and 0.54 (95% CI: 0.35–0.73) in the Changshu cohort. The corresponding specificities were 0.90 (95% CI: 0.83–0.95) in the Hohhot cohort and 0.94 (95% CI: 0.84–1.00) in the Changshu cohort. In subgroup analyses, HE4 had an AUC (95% CI) of 0.78 (0.71–0.85) in exudates and an AUC of 0.69 (0.57–0.81) in patients with negative effusion cytology. The DCA revealed that HE4 determination had a net benefit in both cohorts.

Conclusion

Pleural fluid HE4 has moderate diagnostic accuracy for MPE and has net benefit in pleural effusion patients with unknown etiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsPleural EffusionPleural Effusion, MalignantHumansMaleBiomarkers, TumorEpididymisExudates and TransudatesProspective StudiesDouble-Blind Method

Stichwörter der Autor:innen

HE4diagnostic accuracymalignant pleural effusionsensitivityspecificity

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
  • Department of Medical Experiment Center, The Basic Medical Sciences College of Inner Mongolia Medical University, Hohhot, China.
  • Department of Parasitology, The Basic Medical Sciences College of Inner Mongolia Medical University, Hohhot, China.
  • Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
  • Department of Pulmonary and Critical Care Medicine, Affiliated Changshu Hospital of Nantong University, Changshu, China.
  • Department of Laboratory Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, ChinaDepartment of Parasitology, The Basic Medical Sciences College of Inner Mongolia Medical University, Hohhot,…

ORCID-Profile: Zhi-De Hu

Förderung

  • The Natural and Science Foundation of Inner Mongolia Autonomous Region for Distinguished Young Scholars
  • The Science and Development Program of Gusu School, Nanjing Medical University

Zitieren

APA

Yang, Q., Niu, Y., Wen, J. X., Yang, D. N., Han, Y. L., Wen, X. H., Yan, L., Huang, J. H., Chen, H., Zheng, W. Q., Jiang, T. W., & Hu, Z. D. (2023). Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666231216566

Vancouver

Yang Q, Niu Y, Wen JX, Yang DN, Han YL, Wen XH, et al. Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts. Therapeutic Advances in Respiratory Disease. 2023. doi:10.1177/17534666231216566

BibTeX
@article{Yang2023,
  author = {Yang, Qian and Niu, Yan and Wen, Jian-Xun and Yang, Dan-Ni and Han, Yu-Ling and Wen, Xu-Hui and Yan, Li and Huang, Jin-Hong and Chen, Hong and Zheng, Wen-Qi and Jiang, Ting-Wang and Hu, Zhi-De},
  title = {Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2023},
  doi = {10.1177/17534666231216566}
}
Kostenlos starten →